92 related articles for article (PubMed ID: 15967326)
1. The variable risk of colorectal cancer in patients with inflammatory bowel disease.
Lindgren S
Eur J Intern Med; 2005 Jun; 16(3):139-140. PubMed ID: 15967326
[No Abstract] [Full Text] [Related]
2. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
[TBL] [Abstract][Full Text] [Related]
3. [Colorectal cancer in inflammatory bowel disease].
Henriksen M; Moum B
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
[TBL] [Abstract][Full Text] [Related]
4. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
de Jong DJ; Nagengast FM
Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2758-60. PubMed ID: 18232192
[TBL] [Abstract][Full Text] [Related]
5. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
7. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
Beaugerie L; Sokol H; Seksik P
Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
Canavan C; Abrams KR; Mayberry J
Aliment Pharmacol Ther; 2006 Apr; 23(8):1097-104. PubMed ID: 16611269
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
10. Distress among inflammatory bowel disease patients at high risk for colorectal cancer: a preliminary investigation of the effects of family history of cancer, disease duration, and perceived social support.
Rini C; Jandorf L; Valdimarsdottir H; Brown K; Itzkowitz SH
Psychooncology; 2008 Apr; 17(4):354-62. PubMed ID: 17607717
[TBL] [Abstract][Full Text] [Related]
11. Clinical study of the relationship between inflammatory bowel diseases and colorectal neoplasms.
Zhao YJ; Yuan YZ
J Dig Dis; 2009 May; 10(2):113-7. PubMed ID: 19426393
[TBL] [Abstract][Full Text] [Related]
12. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
Vleggaar FP; Lutgens MW; Claessen MM
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
[TBL] [Abstract][Full Text] [Related]
13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.
Goessling W; Mayer RJ
Gastroenterol Clin North Am; 2006 Sep; 35(3):713-27. PubMed ID: 16952747
[TBL] [Abstract][Full Text] [Related]
15. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
Risques RA; Rabinovitch PS; Brentnall TA
Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
17. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?
Giannini EG; Kane SV; Testa R; Savarino V
Dig Liver Dis; 2005 Oct; 37(10):723-31. PubMed ID: 16023905
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions.
Konda A; Duffy MC
Gastroenterol Clin North Am; 2008 Mar; 37(1):191-213, viii. PubMed ID: 18313546
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer after orthotopic liver transplantation.
Silva MA; Jambulingam PS; Mirza DF
Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
[TBL] [Abstract][Full Text] [Related]
20. Associated neoplastic disease in inflammatory bowel disease.
Cendan JC; Behrns KE
Surg Clin North Am; 2007 Jun; 87(3):659-72. PubMed ID: 17560418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
